Of note, CHIP with somatic mutations was detected in 10% of the elderly study participants, with increasing frequency with age; in the tested cohort, up to 7 years after DNA sampling, approximately 42% of subjects who displayed clonality at the time of sampling developed hematological cancer. Here, STUB1 is linked to hematopoietic and lymphoid cell neoplasm.